URSAPHARM launches information campaign to raise awareness about pre- and post-operative care for the eyes and eyelids
Saarbrücken, September 11, 2025. As part of an information campaign in the second half of the year, the pharmaceutical company URSAPHARM is focusing on the importance of coordinated pre- and post-operative care for the eyes and eyelids. The campaign is based on URSAPHARM’s range of eye lubrication and the therapy concept for healthy eyelids, which was launched internationally in 2024. The therapeutic approach aims to provide individual treatment and care for eyelid margin inflammation (blepharitis) and meibomian gland dysfunction and includes the POSIFORLID® range of products for heat treatment, daily eyelid margin hygiene and care and the treatment of eyelid disorders. The approach is complemented by EvoTears® OMEGA eye drops for evaporative dry eye syndrome. Certified lubricating eye drops from the HYLO® range can be used for postoperative eye lubrication. The aim of the communication is to educate people about the importance of adequate eyelid hygiene prior to eye surgery and pre- and postoperative eye lubrication. The campaign includes measures at the point of sale, training for pharmacy staff, as well as advertisements and advertorials in the medical and pharmaceutical press. The various measures are spread over the entire second half of the year.
Details of the awareness campaign
In order to minimise the risk of short-term cancellations of eye surgeries such as cataract surgery or IVOM treatments (IVOM = intravitreal drug administration) – e.g. due to eyelid margin disorders such as blepharitis – URSAPHARM is using various channels to provide information on the importance of targeted eyelid margin hygiene in preoperative care and on pre- and postoperative eye lubrication. These include advertorials and traditional advertisements in the pharmacy and ophthalmological trade press, as well as a training programme for pharmacy staff on the topic of eye health as part of the this year’s “ApothekenTour”. This focuses on clinical pictures (dry eye, blepharitis, meibomian gland dysfunction) and the corresponding treatment concepts (HYLO® product family, POSIFORLID® – the concept for healthy eyelids). URSAPHARM has been raising awareness for eyelid hygiene in pharmacies with displays since the beginning of the year.
Basic therapy: For adequate eyelid hygiene
The basic treatment for healthy eyelids consists of heat treatment with the POSIFORLID® eye mask followed by eyelid hygiene. The eyelids can first be cleaned with POSIFORLID® eyelid hygiene wipes. POSIFORLID® eye spray is an integral part of the treatment, providing additional care after cleaning or in between. The eyelid margin should be cleaned daily in the morning and evening. Studies have shown that eyelid margin hygiene has a comparable effect to the administration of antibiotic eye drops.1,2 Regular cleaning and care is also recommended during symptom-free periods in order to maintain or improve the function of the Meibomian glands.
An overview of the individual products and their effectiveness
POSIFORLID® eye mask (medical device)
The POSIFORLID® eye mask, which heats itself up using a click system, enables simple and effective heat treatment for blepharitis, meibomian gland dysfunction, styes and chalazion. It emits constant heat of approximately 45 °C for 10 minutes. The mask is secure and cannot overheat. Moistened cotton pads inserted into the mask create a warm, moist environment. This helps to soften crusts or deposits on the eyelid margin and loosen the accumulated secretions in the Meibomian glands. Massaging the eyelids afterwards helps to remove the liquefied secretion from the sebaceous glands. The heat treatment thus supports the maintenance and improvement of the function of the Meibomian glands and should be used twice a day (morning and evening). The mask can be reused up to 90 times.
POSIFORLID® eyelid hygiene wipes (cosmetic)
POSIFORLID® eyelid hygiene wipes are pre-moistened, sterile disposable wipes and can be used without age restriction to gently cleanse deposits (e.g. dust, pollen) and crusts on the eyelids or between the eyelashes. They are suitable for cleaning and caring for the eyelid margins in cases of blepharitis and soothe irritated eyelid skin. The ingredients hyaluronic acid, horsetail and euphrasia can relieve skin irritation. POSIFORLID® eyelid hygiene wipes are used after heat treatment and massage to cleanse the eyelids.
POSIFORLID® eye spray (cosmetic)
POSIFORLID® eye spray contains euphrasia, hyaluronic acid and salicylic acid. It can be easily sprayed onto the closed eyes to provide supportive care for eyelid inflammation and irritated eyelids. It gently dissolves deposits on the eyelids and between the eyelashes while soothing irritated eyelids. Thanks to its ease of use, POSIFORLID® eye spray makes daily eyelid care a quick and easy routine, whether at home or on the go.
HYLO CARE®, HYLO COMOD® and HYLO GEL® (medical devices)
The lubricating eye drops HYLO CARE®, HYLO COMOD® and HYLO GEL® can be used for pre- and post-operative care of the eye. Thanks to their long-lasting lubricating effect, they support the regeneration of damaged eye surfaces, for example after surgical procedures. This can prevent dry eye syndrome, which is a possible post-operative complication. As the wound healing process can only proceed optimally in a sufficiently moist environment, a stable tear film is essential after intraocular and refractive surgery. Preoperative stabilisation of the tear film also improves the quality of preoperative measurement data and reduces the likelihood of refractive errors after eye surgery.
1 Sung, J., et al., Randomised double-masked trial of eyelid cleansing treatments for blepharitis. Ocul Surf, 2018. 16(1): p. 77-83.
2 Peral, A., et al., Importance of Lid Hygiene Before Ocular Surgery: Qualitative and Quantitative Analysis of Eyelid and Conjunctiva Microbiota. Eye Contact Lens, 2016. 42(6): p. 366-370.
About URSAPHARM
Highest quality from URSAPHARM – made in Germany
URSAPHARM Arzneimittel GmbH is an internationally operating, medium-sized pharmaceutical company that has established as the market leader in Germany and one of the leading suppliers in Europe thanks to its broad and high-quality product range in the field of ophthalmology. Since its foundation in 1974, URSAPHARM has been a guarantor for the consistent transfer of innovative pharmaceutical concept into successful medicinal products and medical devices. One of the most successful developments of the company is the HYLO® product family with eye drops and ointment for lubricating the eyes. The product portfolio is rounded off by various preparations for general medicine in the form of film-coated tablets, capsules, granules, sprays and ointments. In addition, URSAPHARM provides its expertise in development, production, quality control and quality assurance as a high-performance contract manufacturer and co-operation partner worldwide. Headquartered in Saarbrücken, the company has subsidiaries in France, Netherlands, Italy, Austria, Switzerland, Poland, the Czech Republic, Portugal, Russia and India as well as co-operation agreements with distribution partners in over 80 countries.
If you have any questions, please contact:
dot. communications GmbH
Tel.: 089/530797-23
E-Mail: ursapharm@dot-communications.de